| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_781234f3bbb66c6fda75dc8db9f2a283 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
1999-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75cf7fd0a67961d3c56a6eb9876e01a7 |
| publicationDate |
2000-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-19921794-A1 |
| titleOfInvention |
New pharmaceutical composition |
| abstract |
The invention relates to a pharmaceutical composition containing a combination of at least one antimycotic, polydocanol and optionally salicylic acid as active ingredients, for the local treatment of skin diseases caused by the lipophilic yeast Malassezia furtur. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8952070-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2793833-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7101889-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9561279-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10326959-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012107565-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03070204-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03070204-A2 |
| priorityDate |
1999-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |